Combination of Herceptin® with Non–anthracycline-based Chemotherapy Appears to Be Effective (12-15-2009)

Among women with early, HER2-positive breast cancer, the addition of Herceptin® (trastuzumab) to adjuvant chemotherapy reduces the risk of cancer recurrence and improves survival. Herceptin provides a benefit in combination with either anthracycline-... Continue Reading